ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. Funds and ETFs Asymchem Laboratories (Tianjin) Co., Ltd. Hong Kong S.E.
Equities
6821
CNE100004Z06
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64 HKD | -0.78% |
|
+0.79% | -29.67% |
| 04-29 | Asymchem Laboratories' Profit Drops 55%, Operating Income Slumps 38% in Q1; Shares Up 3% | MT |
| 04-26 | Nomura Adjusts Asymchem Laboratories’ Price Target to HK$83.94 From HK$90.12 Keeps at Buy | MT |
ETFs positioned on Asymchem Laboratories (Tianjin) Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.74% | 4 M€ | -27.92% |
Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is also engaged in the provision of pharmaceutical formulation solutions, biosynthetic solutions and clinical solutions.
Sector
Pharmaceuticals
Calendar
14/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
85.01
CNY
Average target price
99.42
CNY
Spread / Average Target
+16.96%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +17.13% | 239B | |
| +8.00% | 204B | |
| -7.69% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- 002821 Stock
- 6821 Stock
- Funds and ETFs Asymchem Laboratories (Tianjin) Co., Ltd.
